MOET HENNESSY RECH has a total of 17 patent applications. Its first patent ever was published in 1985. It filed its patents most often in France, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are YAKURIGAKU CHUO KENKYUSHO KK, ARCH PERSONAL CARE PRODUCTS L and COLOMER GROUP SPAIN S L.
# | Country | Total Patents | |
---|---|---|---|
#1 | France | 5 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Spain | 2 | |
#5 | Canada | 1 | |
#6 | Republic of Korea | 1 | |
#7 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Specific use of cosmetics | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Unspecified technologies | |
#5 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Meybeck Alain | 16 |
#2 | Redziniak Gerard | 8 |
#3 | Michelon Philippe | 5 |
#4 | Montastier Christiane | 5 |
#5 | Dumas Marc | 4 |
#6 | Megnin Jean-Pierre | 2 |
#7 | Marechal Christian | 2 |
#8 | Beybeck Alain | 1 |
Publication | Filing date | Title |
---|---|---|
FR2616328A1 | Composition based on hydrated lipid lamid phases or liposomes containing murier extract, or at least one flavone, particularly a kuwanone and pharmaceutical composition, especially dermatological, with depigmentary, or anti-inflamment activity, or anti-inflament, | |
FR2616325A1 | Composition containing hydroquinone and kojic acid and pharmaceutical composition, especially dermatological, with depigmenting or anti-inflammatory activity, or cosmetic comprising kojic acid and hydroquinone | |
FR2610521A1 | Novel cosmetic compositions having improved substantivity and / or adhesion | |
FR2594847A1 | Process for the preparation of biologically active polypeptides, polypeptides obtained and compositions containing them | |
FR2591105A1 | Pharmaceutical composition, in particular dermatological, or cosmetic, based on hydrated lipid lamellar phases or liposomes containing a retinoide or a structural analog of such a retinoid as a carotenoid. |